Modified STEMI protocol for PPCI during COVID-19 Pandemic: Does it prolong Door-To-Balloon performance?
Abstract
Background
COVID-19 became a main health problem and causes heavy impact, especially for healthcare system. Managing ST-Segment Elevation Myocardial Infarction (STEMI) patients before COVID-19 pandemic was already challenging enough for Healthcare Professionals (HCP) to pursue time-sensitive treatment. After COVID-19 pandemic, the time-sensitive treatment of pursuing door-to-balloon (DTB) time put a lot more burden to HCP. In this study, We sought to analyze how a change in protocol of PPCI in STEMI patients before and during the pandemic influence the performance of DTB in the hospital.
Methods
This is a single-centered retrospective observational study among STEMI patients which was treated by PPCI. Secondary data from the medical record were collected consecutively from April 2018 to January 2022 (46 months). We compared DTB performances before and during the pandemic.
Result
During 46 months period, the total population of this research was 880 patients. There were total 358 patients underwent PPCI before the pandemic and 522 patients after the pandemic. Modified protocol with the addition step to prevent the spread of COVID-19 had been implemented since April 2020. DTB increased significantly during the pandemic (90 (70-124) minutes vs 97 (76-135) minutes, p 0.002). The proportion of the patients who achieved DTB under 90 min was also significantly decreasing (56.4% vs 47.9%, p 0.0013).
Conclusion
It is necessary for PPCI center to modify PPCI workflow during the pandemic. A decent workflow should consider practicality and simplicity without compromising HCP and patient safety. Implementing modified PPCI workflow during the pandemic significantly increased DTB time but it is still within the limit of being reasonable and acceptable for the benefit of the patients.
Downloads
References
2. Ruben C, Carlos C. Decrease in the number of primary angioplasty procedures during the pandemic and its relationship with mortality from COVID-19. The role of competing risks. Rev Esp Cardiol. 2021;74(5):462–476.
3. Giuseppe D, Monica V, Miha C, et al. Impact of COVID-19 Pandemic on Primary PCI for STEMI. J Am Coll Cardiol. 2020;76.
4. Chun K, Chris P, Tim K, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart BMJ. 2020;106:1805–1811.
5. Isman F, Renan S, Anwar S, et al. Panduan Diagnosis dan Tatalaksana Penyakit Kardiovaskular pada Pandemi Covid-19 (Terjemahan Dokumen European Society of Cardiology 21 April 2020). Jakarta: Ina Heart Association; 2020. p. 26-35, 51-57.
6. Collin B, Daniel A, Elena A, et al. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2 care pathways, treatment, and follow-up: The Task Force for the management of COVID-19 of the European Society of Cardiology. Eur Heart J. 2022;43:1059–1103.
7. Borja I, Stefan J, Stefan A, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119–177.
8. Yuki M, Takuya I, Soichiro W, et al. Impact of the SARS CoV-2 Pandemic on Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction. Int Heart J. 2021;62:1230-1234.
9. Patrick T, Frederick G, Deborah D, et al. Guidelines in review: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circ J. 2014;21:190–191.
10. Nicholas W, Ching H , Hwee L, et al. Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention (Results From the Singapore Western STEMI Network). Circ J. 2021; 85: 139–149.
11. Sunanto N, Dafsah A. Tantangan Penatalaksanaan STEMI di Pandemi Covid-19. IJC. 2020:41:91-97.
12. Cong Y, Jia X, Jian Q, et al. COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients. MedRxiv. 2020;03.
Full text (PDF) downloads: 199
Copyright (c) 2024 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
